EULAV Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-129,000
Closed -$2.98M 297
2018
Q2
$2.98M Sell
129,000
-98,000
-43% -$2.33M 0.14% 167
2018
Q1
$5.59M Sell
227,000
-132,000
-37% -$3.47M 0.27% 124
2017
Q4
$9.63M Hold
359,000
0.46% 71
2017
Q3
$8.64M Hold
359,000
0.41% 80
2017
Q2
$7.7M Hold
359,000
0.38% 90
2017
Q1
$6.15M Hold
359,000
0.31% 109
2016
Q4
$6.44M Hold
359,000
0.35% 102
2016
Q3
$7.46M Hold
359,000
0.4% 94
2016
Q2
$9.65M Hold
359,000
0.53% 66
2016
Q1
$9.73M Buy
359,000
+24,000
+7% +$643K 0.54% 66
2015
Q4
$9.73M Hold
335,000
0.53% 68
2015
Q3
$9.09M Hold
335,000
0.52% 74
2015
Q2
$9.17M Hold
335,000
0.48% 77
2015
Q1
$8.94M Hold
335,000
0.46% 82
2014
Q4
$7.09M Sell
335,000
-131,000
-28% -$2.93M 0.38% 105
2014
Q3
$11.1M Sell
466,000
-180,000
-28% -$4.14M 0.6% 49
2014
Q2
$14.9M Hold
646,000
0.8% 19
2014
Q1
$14.7M Hold
646,000
0.8% 17
2013
Q4
$11.9M Hold
646,000
0.65% 38
2013
Q3
$10.9M Hold
646,000
0.64% 39
2013
Q2
$10M Buy
+646,000
New +$10.8M 0.61% 42

Other funds holding NVO

EULAV Asset Management's NVO Position: Q3 2018 in Review

EULAV Asset Management sold out of Novo Nordisk (NVO) in Q3 2018, closing a stake of 129,000 shares — an estimated $2.98M sold.

EULAV Asset Management first reported a position in NVO in Q2 2013 and held it in 21 quarters. The position peaked at $14.9M in Q2 2014. 557 funds tracked by Wall St. Rank hold NVO as of Q3 2018.

  • EULAV Asset Management reported no remaining Novo Nordisk position as of Q3 2018 after selling out during the quarter.
  • EULAV Asset Management sold 129,000 Novo Nordisk shares in Q3 2018, an estimated $2.98M.
  • EULAV Asset Management first reported a position in Novo Nordisk in Q2 2013 and held it in 21 quarters.
  • EULAV Asset Management's Novo Nordisk position peaked at $14.9M in Q2 2014.
  • 557 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2018.

Based on EULAV Asset Management's 13F filing for Q3 2018, filed 26 Oct 2018.